Purpose 28
Introduction
. 70
Typically, for lung tumors the clinical target volume (CTV) is enlarged to the internal target 71
volume (ITV) with the intent of ensuring sufficient tumor coverage in the presence of motion 5 .
72
This strategy can result in excessive irradiation of surrounding healthy tissue, or marginal 73 miss of the tumor 6 . The high doses required for tumor control are close to or above the 74 tolerance level for healthy tissues, resulting in increased side effects, or requiring a reduction 75 in dose to the tumor, decreasing tumor control probability (TCP) 7, 8 . In this way, 76 compensating for the presence of respiratory motion of lung tumors can improve the 77 therapeutic ratio and thus survival rates 9 .
78
One way to compensate for tumor motion is by means of real-time tumor tracking and 79 motion compensation 8, [10] [11] [12] [13] [14] . Motion tracking is complicated by variations in baseline (the 80 position about which the quasi-periodic motion occurs), frequency, oscillatory amplitude and 81 oscillatory form, despite the overall superficial regularity of respiratory motion. These effects 82 can differ widely between patients but can also vary over the course of treatment of a single 83 correlating surrogate data to tumor motion have been so-called 'black box' or 'grey box' 104 approaches, for which the internal behavior of the physical system is not or only partially 105 known, respectively. These models consider the input and output data, but not the exact 106 physical relationship between them. Various approaches of this form include linear 107 correspondence models 9, 28 , composites of baseline drift, frequency variation, fundamental 108 pattern change and random observation noise To overcome some of the physical intrinsic limitations for the practical application of the 129 above approach, the first aim of this paper was to refine the Wilson and Meyer model in the 130 one-dimensional realm. The relationship between lung tumor and external abdominal marker 131 movement is considered for the primary dimension of motion, namely the SI direction for the 132 tumor and the AP direction for the abdominal signal. The second objective was to apply the 133 refined model to a large and realistic clinical data set of tumor motion from a cohort of lung 134 cancer patients treated with the Mitsubishi Real-Time Radiation Therapy system in Sapporo, 135
Japan to investigate the model behavior on an intra-and inter-patient specific basis. 136 137
Material and Methods 138

Mathematical model 139
Following the methodology of Wilson & Meyer 35 , we model the correlation between the 140 surrogate data provided by abdominal motion and the target data of the lung tumor motion 141 with a pseudo-mechanical system. This system is composed of springs and dashpots, the 142 latter providing a damping effect. In general, a spring-dashpot unit can be composed of 143 springs and dashpots in series, parallel, or some combination thereof. Three of the most 144 frequently-used configurations in other applications are shown in Figure 1 
Numerical approach 180
Equation (1) was rewritten as two coupled first-order ordinary differential equations, which 181
were solved for each set of training data using the MATLAB™ differential equation solver 182 ode45, which is recommended for non-stiff problems 
Clinical data 206
The clinical data consist of 3D internal fiducial-based motion obtained using radiopaque 207 fiducial markers implanted and visualized in real-time using stereoscopic diagnostic x-ray 208 fluoroscopy, collected using a Mitsubishi Real-Time Radiation Therapy system, at the 209 Nippon Telegraph and Telephone Corporation Hospital, Sapporo, Japan
27
. This was 210 obtained simultaneously with 1D external abdominal motion, collected on an independent 211 co-ordinate system using a laser based AZ-733V "RespGate" made by Anzai Medical, 212
Tokyo, Japan. The data set consisted of motion results from eleven patients (patient 1-11) 213
with lung cancer at various sites, with a total of 171 treatment beams for up to ten 214 consecutive treatment fractions (day 1-10) and four beam configurations per fraction (beam 215
. The data for patient 11 were unreliable and not included. The patients were not a 216 random sample of the general lung cancer population, but were selected on the basis of an 217 estimated internal marker motion of more than 10 mm peak to peak (SI, lateral or AP 218 direction). The data show phase shifts of the internal-external data (one signal lagging the 219 other) in the SI direction that are mostly between 100 and 200 ms. 220
The data were not acquired in a common coordinate system with absolute spatial co-221 ordinates and therefore they could not be normalized to a common reference point. Spatial In the second stage, for each patient the optimal parameters determined for an arbitrarily 231 chosen single beam were applied to data from other beams and treatment days to 232 investigate whether a beam-specific set of model parameters is adequate to model tumor 233 motion over a course of treatment. 234
We also investigate the ability of the model to adapt to irregularities in the clinical data such 235 as unclear tracking data, missing data points, baseline drift and amplitude and frequency 236 variation. 237
Results 238
Stage 1 239
Applying the optimization algorithm to the data from the 52 clinical treatment beams with the 240 initial estimate parameter triplet (ω, λ, δ) = (10 Table 2 . 289
When the robustness of the model was examined with respect to the linear relationship 290 between the tumor position and model prediction, the mean correlation coefficient of the 52 291 beams was 0.96, the same value as when each beam was optimized independently. 292
There was a drop in residency in this second stage as can be seen from Table 3 . This time a 293 band width of 2.6 mm was required on average, an increase of 0.60 mm, for 95% residency. 294 295 
Detailed analysis of Patients 7, 8, and 10 306
The means in Table 2 for patients 7, 8, and 10 were obtained from a subset of data available 307 for those patients. Now we consider all available and reliable data for patients 7, 8, and 10 to 308 determine whether our initial use of a subset of data biased the results shown in Table 2 . In 309 Patient 10, and all 52 beams studied. The average value given is the mean ± one standard 319
deviation. 320
Average RMS error
Band width for 95% residency One beam was omitted for patient 10 because it contained a substantial amount of missing data, and obviously spurious measurements.
width required for 95% residency was small as can be seen from 
Irregular beam data 334
The model was capable of dealing with data containing irregularities such as missing data 335 covering several seconds (poor tracking of the abdominal motion), spikes in the amplitude of 336 tumor motion and baseline drift. Figure 5 shows an example of the model applied to data 337 containing some initial baseline drift of the breathing signal, a period of missing data, and an 338 unusual rapid variation in amplitude, or "spike". These data problems are important 339 considerations for modeling lung tumor motion to ensure that errors are not avoidably high. histogram is long relative to those shown in Figure 4 . This is not due to poor systematic 362 performance but rather due to the performance in the short dashpot-mediated recovery 363 period immediately following the spike in Figure 5 , lasting less than one second. 364 The model was applied to clinical tumor tracking data from 10 patients treated on the 374
Mitsubishi Real-Time Radiation Therapy system in Sapporo, Japan. In the first stage, the 375 model parameters were optimized for each individual beam in order to determine the 376 goodness of fit for each data set. These values served as a benchmark for further evaluation 377 in Stage 2. In Stage 2, the optimized model parameters for one particular beam were used to 378
properties. 391
To put the results into a more clinically relevant context, hypothetical bounds were calculated 392 so that the modeled point location of the tumor would be within the actual point location of 393 the tumor for 95% of the treatment time. This hypothetical bound would account for the 394 inaccuracies of the modeling and assumes otherwise perfect compensation of the tumor 395 motion, by tumor tracking or respiratory gating, for example. The bound calculated for stage 396 1 averaged over 52 beams was 2.0 mm and for Stage 2 it was 2.6 mm. To obtain a better 397 understanding of the variability within the patients, three representative patients were further 398 analyzed, patients 7, 8 and 10, corresponding to a residual error of 0.95 mm ('mean'), 1.61 399 mm (poor') and 0.84 mm ('excellent') in Stage 1. The residual errors showed a largely 400
Gaussian distribution with minimal offset from the mean indicating that the model did not 401 result in systematic model output errors. The calculated error bounds based on the 95% 402 inclusion criteria calculated for the selected patients were 2.1, 3.0, 1.7 mm, respectively, 403 which gives an indication of the correlation between the residual modeling errors and the 404 resulting position uncertainty, which ultimately feeds into the calculation of appropriate 405
margins. 406
One of the useful features of the spring-dashpot system is that it managed to successfully 407 model baseline drifts and irregular tumor motion. It was also capable of quickly restoring 408 accurate model output when data were missing as shown in Figure 5 . The determination of 409 optimal modeling parameters did not include a systematic search of the global parameter 410 space; a downhill search algorithm was used for efficiency. It remains to be investigated if a 411 stochastic search technique, e.g. simulated annealing or approximate Bayesian 412 computation, is required to remove dependence on the initial parameter estimates, but this 413 will be at the expense of higher computational costs. For consistency the initial starting 414 condition for the search was kept constant but it was found that the nominal values of the 415 optimized parameters diverged if different starting conditions were used (data not shown). 416
However, it was found that the resulting residuals were almost identical, which indicates that 417 the solution space is relatively flat. Therefore it was not considered critical but remains an 418 area of further investigation. ) to adjust 435 to the determined change in position. In this context, we also note that phase lag is a well-436 known effect in spring-dashpot models, but we have not investigated any correlation 437 between the lag and the parameters of the current model. Ultimately, any algorithm has 438 limitations and is dependent on the quality of the input data and therefore the output of the 439 model should be tested and verified with independent means in a clinical setting. 440
Conclusion 441
A semi-physical spring-dashpot model to correlate breathing to tumor motion in the superior-442 inferior direction has been presented and applied to clinical tracking data. Optimized model 443 parameters were found to be robust and transferrable to different beams on the same day 444 and consecutive days. Day-to-day variations in the agreement between the model output 445 and the measured data were small, indicating that the model parameters may be determined 446 prior to or on the first day of treatment and then used throughout the course of treatment. 447
The semi-physical nature of the model enabled it to deal with irregularities in the data such 448 as baseline drifts, phase shifts and amplitude and frequency variations. Further work will 449 address the expansion of the model to include all three dimensions and experimental testing 450
and verification of the model output in a clinical setting. 451
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